21 CFR 522.1315
§ 522.1315 Maropitant.
United States · 21 CFR — Food and Drugs · Status: effective
Cite this
- Citation
- 21 CFR 522.1315, § 522.1315 Maropitant, United States, version 1 as recorded 2026-07-09, yourstate.us, https://yourstate.us/provision/87478
- Permanent ID
ys:prov:87478@1- SHA-256
2c345f02e19c9a96532cf540d86f375457263c5547d0ba3b618001990e0bef09
The hash is SHA-256 of this version's text, with every run of whitespace collapsed to a single space and the ends trimmed. The ID always leads back here, and checking it says whether the text you cited is still the current version.
Full text
(a) Specifications. Each milliliter of solution contains 10 milligrams (mg) maropitant as maropitant citrate.
(b) Sponsor. See Nos. 054771 and 017033 in § 510.600(c) of this chapter.
(c) Conditions of use—(1) Dogs—(i) Amount. Administer 1.0 mg per kilogram (mg/kg) of body weight by subcutaneous or intravenous injection once daily for up to 5 consecutive days.
(ii) Indications for use. For the prevention and treatment of acute vomiting.
(iii) Limitations. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
(2) Cats—(i) Amount. Administer 1.0 mg/kg of body weight by subcutaneous or intravenous injection once daily for up to 5 consecutive days.
(ii) Indications for use. For the treatment of vomiting.
(iii) Limitations. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Legislative history
This is a federal regulation, adopted through agency rulemaking under the Administrative Procedure Act — not enacted by a recorded vote of Congress.